Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-06
2007-03-06
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S408000, C514S381000, C514S422000, C548S518000, C548S563000, C548S560000, C548S252000, C548S253000
Reexamination Certificate
active
11208775
ABSTRACT:
The present invention relates to pyrrolo-naphthyl compounds of the formulaand methods of using them to modulate PAI-1 expression and to treat PAI-1 related disorders.
REFERENCES:
patent: 3026325 (1962-03-01), Heinzelman et al.
patent: 3476770 (1969-11-01), Scherrer
patent: 3557142 (1971-01-01), Bell
patent: 3843683 (1974-10-01), Bell
patent: 4478819 (1984-10-01), Hercelin et al.
patent: 4736043 (1988-04-01), Michel et al.
patent: 4851406 (1989-07-01), Martens et al.
patent: 5164372 (1992-11-01), Matsuo et al.
patent: 5234917 (1993-08-01), Finkelstein et al.
patent: 5420289 (1995-05-01), Musser et al.
patent: 5482960 (1996-01-01), Berryman
patent: 5502187 (1996-03-01), Ayer et al.
patent: 5532276 (1996-07-01), Mederski et al.
patent: 5541343 (1996-07-01), Himmelsbach et al.
patent: 5562859 (1996-10-01), Schlosser et al.
patent: 5612360 (1997-03-01), Boyd et al.
patent: 5693637 (1997-12-01), Klinge et al.
patent: 5723499 (1998-03-01), Charpentier et al.
patent: 5859044 (1999-01-01), Dow et al.
patent: 5883090 (1999-03-01), Dorsch et al.
patent: 5952382 (1999-09-01), Bernardon
patent: 6048875 (2000-04-01), De Nanteuil et al.
patent: 6110963 (2000-08-01), Malamas
patent: 6137002 (2000-10-01), Fisher et al.
patent: 6166069 (2000-12-01), Malamas et al.
patent: 6225328 (2001-05-01), Bernardon
patent: 6232322 (2001-05-01), Malamas et al.
patent: 6251936 (2001-06-01), Wrobel et al.
patent: 6302837 (2001-10-01), De Nanteuil et al.
patent: 6479524 (2002-11-01), Priepke et al.
patent: 6586453 (2003-07-01), Dhanoa et al.
patent: 6599929 (2003-07-01), Cho et al.
patent: 6787556 (2004-09-01), Hargreaves et al.
patent: 6800645 (2004-10-01), Cox et al.
patent: 6800654 (2004-10-01), Mayer et al.
patent: 6844358 (2005-01-01), Malamas et al.
patent: 2003/0013732 (2003-01-01), Elokdah
patent: 2003/0018067 (2003-01-01), Elokdah et al.
patent: 2003/0060497 (2003-03-01), Gerlach et al.
patent: 2003/0125371 (2003-07-01), Elokdah et al.
patent: 2004/0116488 (2004-06-01), Jennings et al.
patent: 2004/0116504 (2004-06-01), Elokdah et al.
patent: 2004/0122070 (2004-06-01), Jennings
patent: 2004/0138283 (2004-07-01), Jennings et al.
patent: 2004/0204417 (2004-10-01), Perez et al.
patent: 2005/0070584 (2005-03-01), Havran et al.
patent: 2005/0070585 (2005-03-01), Elokdah et al.
patent: 2005/0070587 (2005-03-01), Elokdah et al.
patent: 2005/0070592 (2005-03-01), Gundersen
patent: 2005/0096377 (2005-05-01), Hu
patent: 2005/0113428 (2005-05-01), Gopalsamy et al.
patent: 2005/0113436 (2005-05-01), Elokdah et al.
patent: 2005/0113438 (2005-05-01), Hu et al.
patent: 2005/0113439 (2005-05-01), Hu
patent: 2005/0119296 (2005-06-01), Elokdah et al.
patent: 2005/0119326 (2005-06-01), Havran et al.
patent: 2005/0119327 (2005-06-01), Hu
patent: 2005/0215626 (2005-09-01), Havran et al.
patent: 2006/0020003 (2006-01-01), Commons et al.
patent: 2006/0052348 (2006-03-01), Commons et al.
patent: 2006/0052420 (2006-03-01), Commons
patent: 3147276 (1983-06-01), None
patent: 43 38 770 (1995-05-01), None
patent: 4341453 (1995-06-01), None
patent: 4341665 (1995-06-01), None
patent: 19543639 (1997-05-01), None
patent: 19753522 (1999-06-01), None
patent: 0 416 609 (1991-03-01), None
patent: 0 445 811 (1991-09-01), None
patent: 0 505 111 (1992-09-01), None
patent: 0 508 723 (1992-10-01), None
patent: 0 512 570 (1992-11-01), None
patent: 0 512 675 (1992-11-01), None
patent: 0 540 956 (1993-05-01), None
patent: 0 560 407 (1993-09-01), None
patent: 0 655 439 (1995-05-01), None
patent: 0 720 982 (1996-07-01), None
patent: 0 759 434 (1997-02-01), None
patent: 0 819 686 (1998-01-01), None
patent: 0 822 185 (1998-02-01), None
patent: 0 955 299 (1999-11-01), None
patent: 1 092 716 (2001-04-01), None
patent: 1 156 045 (2001-11-01), None
patent: 1 321 433 (1973-06-01), None
patent: 2002-275157 (2002-09-01), None
patent: 2004-250400 (2004-09-01), None
patent: 2004-250401 (2004-09-01), None
patent: 91/00277 (1991-01-01), None
patent: 93/10114 (1993-05-01), None
patent: 94/00120 (1994-01-01), None
patent: 94/13637 (1994-06-01), None
patent: 94/14434 (1994-07-01), None
patent: 94/26738 (1994-11-01), None
patent: 95/10513 (1995-04-01), None
patent: 96/06840 (1996-03-01), None
patent: 96/19469 (1996-06-01), None
patent: 96/21656 (1996-07-01), None
patent: 96/26207 (1996-08-01), None
patent: 96/32379 (1996-10-01), None
patent: 97/04774 (1997-02-01), None
patent: 97/09308 (1997-03-01), None
patent: 97/28159 (1997-08-01), None
patent: 97/43260 (1997-11-01), None
patent: 97/48697 (1997-12-01), None
patent: 98/08818 (1998-03-01), None
patent: 99/18099 (1999-04-01), None
patent: 99/28297 (1999-06-01), None
patent: 99/43651 (1999-09-01), None
patent: 99/43654 (1999-09-01), None
patent: 99/43672 (1999-09-01), None
patent: 99/46260 (1999-09-01), None
patent: 99/50268 (1999-10-01), None
patent: 99/58511 (1999-11-01), None
patent: 99/58519 (1999-11-01), None
patent: 99/61435 (1999-12-01), None
patent: 00/18764 (2000-04-01), None
patent: 00/32180 (2000-06-01), None
patent: 00/35919 (2000-06-01), None
patent: 00/46195 (2000-08-01), None
patent: 00/46197 (2000-08-01), None
patent: 00/64876 (2000-11-01), None
patent: 00/64888 (2000-11-01), None
patent: 01/12187 (2001-02-01), None
patent: 01/53298 (2001-07-01), None
patent: 01/83485 (2001-11-01), None
patent: 02/030895 (2002-04-01), None
patent: 02/36590 (2002-05-01), None
patent: 02/072549 (2002-09-01), None
patent: 03/000253 (2003-01-01), None
patent: 03/000684 (2003-01-01), None
patent: 03/031409 (2003-04-01), None
patent: 03/068742 (2003-08-01), None
patent: 03/087087 (2003-10-01), None
patent: 2004/052854 (2004-06-01), None
Aggarwal et al., “A catalytic antibody programmed for torsional activation of amide bond hydrolysis,”Chem. Eur. J., Jan. 25, 2003, 9(13), 3132-3142.
Ballantine, J. A., “The Chemistry of Bacteria,”Journal of the Chemical Society Abstracts, 1957, 2222-2227.
Charlton, Peter, “The status of plasminogen activator inhibitor-1 as a therapeutic target,”Expert Opinion On Investigational Drugs, May 1997, 6(5), 539-554.
Crandall, D. L. et al., “Characterization and comparative evaluation of a structurally unique PAI-1 inhibitor exhibiting oral in-vivo efficacy,”Journal of Thrombosis and Haemostasis, Mar. 17, 2004, 2, 1422-1428.
Da Settimo, A. et al., “Reaction of indole derivatives with bromine, substitution, oxidation, and dimerization,” J Org Chem, 1970, 35(8):2546-2551.
Delgado et al., Journal of Organic Chemistry (1993), 58(10), pp. 2862-2866.
Dillard R. D. et al., “Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A21. Indole 3-Acetamides”,Journal of Medicinal Chemistry, American Chemical Society, 39(26), 5119-5136.
Guzzo, P.R. et al., “Synthesis of a conformationally constrained threonin-valine dipeptide mimetic: design of a potential inhibitor of plasminogen activator inhibitor-1,”Tetrahedron Letters, 2002 43(1), 41-43.
Hipskind, P. A. et al., “Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists,”J Med Chem, 1997, 40(23), 3712-3714.
Julia et al., CA 57:49169, 1962.
Malamas, M. S. et al., “Antihyperglycemic activity of new 1,2,4-oxadiazolidine-3,5-diones,”Eur. J. Med. Chem., 2001, 36, 31-42.
Malamas, M.S. et al. “Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties,”Journal of Medicinal Chemistry, Apr. 6, 2000, 43(7), 1293-1310.
Moody et al., CA 120:298300, 1994.
U.S. Appl. No. 10/947,711, filed Sep. 23, 2004, Gopalsamy et al.
Aznar, J. et al., “Role of Plasminogen Activator Inhibitor Type 1 in the Pathogenesis of Coronary Artery Diseases,”Haemostasis, 24: 243-251 (1994).
Biemond, B. J. et al., “Thrombolysis and Reocclusion in Experimental Jugular Vein and Coronary Artery Thrombosis,”Circulation, 91:1175-1181 (1995).
Carmeliet, P. et al., “Plasminogen Activator Inhibitor—1 Gene-deficient Mice,”Journal of Clinical Investigation, 92: 2756-2760 (Dec. 1993).
Daci, E. et al., “Mice Lacking the Plasmi
Commons Thomas J.
Jenkins Douglas John
Chu Yong
McKane Joseph K.
Woodcock & Washburn LLP
Wyeth
LandOfFree
Pyrrolo-naphthyl acids and methods for using them does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolo-naphthyl acids and methods for using them, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolo-naphthyl acids and methods for using them will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3760995